239 related articles for article (PubMed ID: 34078163)
1. Evidence of cerebral hemodynamic dysregulation in middle-aged APOE ε4 carriers: The PREVENT-Dementia study.
Dounavi ME; Low A; McKiernan EF; Mak E; Muniz-Terrera G; Ritchie K; Ritchie CW; Su L; O'Brien JT
J Cereb Blood Flow Metab; 2021 Nov; 41(11):2844-2855. PubMed ID: 34078163
[TBL] [Abstract][Full Text] [Related]
2. Higher Aortic Stiffness Is Related to Lower Cerebral Blood Flow and Preserved Cerebrovascular Reactivity in Older Adults.
Jefferson AL; Cambronero FE; Liu D; Moore EE; Neal JE; Terry JG; Nair S; Pechman KR; Rane S; Davis LT; Gifford KA; Hohman TJ; Bell SP; Wang TJ; Beckman JA; Carr JJ
Circulation; 2018 Oct; 138(18):1951-1962. PubMed ID: 30018169
[TBL] [Abstract][Full Text] [Related]
3. Interaction of APOE, cerebral blood flow, and cortical thickness in the entorhinal cortex predicts memory decline.
Hays CC; Zlatar ZZ; Meloy MJ; Bondi MW; Gilbert PE; Liu T; Helm JL; Wierenga CE
Brain Imaging Behav; 2020 Apr; 14(2):369-382. PubMed ID: 32048144
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Alzheimer's disease risk with functional magnetic resonance imaging: an arterial spin labeling study.
Bangen KJ; Restom K; Liu TT; Wierenga CE; Jak AJ; Salmon DP; Bondi MW
J Alzheimers Dis; 2012; 31 Suppl 3(0):S59-74. PubMed ID: 22531427
[TBL] [Abstract][Full Text] [Related]
5. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
[TBL] [Abstract][Full Text] [Related]
6. Impact of apolipoprotein E ε4 and HIV on cognition and brain atrophy: antagonistic pleiotropy and premature brain aging.
Chang L; Andres M; Sadino J; Jiang CS; Nakama H; Miller E; Ernst T
Neuroimage; 2011 Oct; 58(4):1017-27. PubMed ID: 21803164
[TBL] [Abstract][Full Text] [Related]
7. Increased hippocampal blood flow in sedentary older adults at genetic risk for Alzheimer's disease.
Zlatar ZZ; Wierenga CE; Bangen KJ; Liu TT; Jak AJ
J Alzheimers Dis; 2014; 41(3):809-17. PubMed ID: 24685629
[TBL] [Abstract][Full Text] [Related]
8. Effect of mild cognitive impairment and APOE genotype on resting cerebral blood flow and its association with cognition.
Wierenga CE; Dev SI; Shin DD; Clark LR; Bangen KJ; Jak AJ; Rissman RA; Liu TT; Salmon DP; Bondi MW
J Cereb Blood Flow Metab; 2012 Aug; 32(8):1589-99. PubMed ID: 22549621
[TBL] [Abstract][Full Text] [Related]
9. Differential association of cerebral blood flow and anisocytosis in APOE ε4 carriers at midlife.
Dounavi ME; Mak E; Swann P; Low A; Muniz-Terrera G; McKeever A; Pope M; Williams GB; Wells K; Lawlor B; Naci L; Malhotra P; Mackay C; Koychev I; Ritchie K; Su L; Ritchie CW; O'Brien JT
J Cereb Blood Flow Metab; 2023 Oct; 43(10):1672-1684. PubMed ID: 37132287
[TBL] [Abstract][Full Text] [Related]
10. Different posterior hippocampus and default mode network modulation in young APOE ε4 carriers: a functional connectome-informed phenotype longitudinal study.
Zheng LJ; Lin L; Schoepf UJ; Varga-Szemes A; Savage RH; Zhang H; Wang YF; Zhang XY; Luo S; Liu Y; Yang GF; Lu GM; Zhang LJ
Mol Neurobiol; 2021 Jun; 58(6):2757-2769. PubMed ID: 33496907
[TBL] [Abstract][Full Text] [Related]
11. Association of Apolipoprotein E ε4 With Medial Temporal Tau Independent of Amyloid-β.
Therriault J; Benedet AL; Pascoal TA; Mathotaarachchi S; Chamoun M; Savard M; Thomas E; Kang MS; Lussier F; Tissot C; Parsons M; Qureshi MNI; Vitali P; Massarweh G; Soucy JP; Rej S; Saha-Chaudhuri P; Gauthier S; Rosa-Neto P
JAMA Neurol; 2020 Apr; 77(4):470-479. PubMed ID: 31860000
[TBL] [Abstract][Full Text] [Related]
12. Impact of sex and
Wang R; Oh JM; Motovylyak A; Ma Y; Sager MA; Rowley HA; Johnson KM; Gallagher CL; Carlsson CM; Bendlin BB; Johnson SC; Asthana S; Eisenmenger L; Okonkwo OC
J Cereb Blood Flow Metab; 2021 Nov; 41(11):3016-3027. PubMed ID: 34102919
[TBL] [Abstract][Full Text] [Related]
13. APOE modifies the interaction of entorhinal cerebral blood flow and cortical thickness on memory function in cognitively normal older adults.
Hays CC; Zlatar ZZ; Meloy MJ; Bondi MW; Gilbert PE; Liu TT; Helm JL; Wierenga CE
Neuroimage; 2019 Nov; 202():116162. PubMed ID: 31493534
[TBL] [Abstract][Full Text] [Related]
14. The association of APOE ε4 with cognitive function over the adult life course and incidence of dementia: 20 years follow-up of the Whitehall II study.
Gharbi-Meliani A; Dugravot A; Sabia S; Regy M; Fayosse A; Schnitzler A; Kivimäki M; Singh-Manoux A; Dumurgier J
Alzheimers Res Ther; 2021 Jan; 13(1):5. PubMed ID: 33397450
[TBL] [Abstract][Full Text] [Related]
15. Anterior Cingulate Structure and Perfusion is Associated with Cerebrospinal Fluid Tau among Cognitively Normal Older Adult APOEɛ4 Carriers.
Hays CC; Zlatar ZZ; Meloy MJ; Osuna J; Liu TT; Galasko DR; Wierenga CE
J Alzheimers Dis; 2020; 73(1):87-101. PubMed ID: 31743999
[TBL] [Abstract][Full Text] [Related]
16. Association of parental dementia with cognitive and brain MRI measures in middle-aged adults.
Debette S; Wolf PA; Beiser A; Au R; Himali JJ; Pikula A; Auerbach S; Decarli C; Seshadri S
Neurology; 2009 Dec; 73(24):2071-8. PubMed ID: 20007524
[TBL] [Abstract][Full Text] [Related]
17. Effect of ApoE epsilon4 allele on visual evoked potentials and resultant flow coupling in patients with Alzheimer.
Rosengarten B; Paulsen S; Burr O; Kaps M
J Geriatr Psychiatry Neurol; 2010 Sep; 23(3):165-70. PubMed ID: 20430978
[TBL] [Abstract][Full Text] [Related]
18. APOE4 is associated with greater atrophy of the hippocampal formation in Alzheimer's disease.
Pievani M; Galluzzi S; Thompson PM; Rasser PE; Bonetti M; Frisoni GB
Neuroimage; 2011 Apr; 55(3):909-19. PubMed ID: 21224004
[TBL] [Abstract][Full Text] [Related]
19. CSF ApoE predicts clinical progression in nondemented APOEε4 carriers.
van Harten AC; Jongbloed W; Teunissen CE; Scheltens P; Veerhuis R; van der Flier WM
Neurobiol Aging; 2017 Sep; 57():186-194. PubMed ID: 28571653
[TBL] [Abstract][Full Text] [Related]
20. Fluoro-2-deoxy-D-glucose (FDG)-PET in APOEepsilon4 carriers in the Australian population.
Rimajova M; Lenzo NP; Wu JS; Bates KA; Campbell A; Dhaliwal SS; McCarthy M; Rodrigues M; Paton A; Rowe C; Foster JK; Martins RN
J Alzheimers Dis; 2008 Mar; 13(2):137-46. PubMed ID: 18376055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
